C. P. Worman

1.6k total citations
61 papers, 1.2k citations indexed

About

C. P. Worman is a scholar working on Immunology, Genetics and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, C. P. Worman has authored 61 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Immunology, 30 papers in Genetics and 19 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in C. P. Worman's work include Chronic Lymphocytic Leukemia Research (29 papers), Monoclonal and Polyclonal Antibodies Research (19 papers) and T-cell and B-cell Immunology (14 papers). C. P. Worman is often cited by papers focused on Chronic Lymphocytic Leukemia Research (29 papers), Monoclonal and Polyclonal Antibodies Research (19 papers) and T-cell and B-cell Immunology (14 papers). C. P. Worman collaborates with scholars based in United Kingdom, Australia and Austria. C. P. Worman's co-authors include John C. Cawley, Andrew P. Jewell, Frank Giles, C. R. Barker, A. H. Goldstone, JC Cawley, Peter C. L. Beverley, Peter M. Lydyard, Robin E. Callard and P M Lydyard and has published in prestigious journals such as Nature, Kidney International and European Journal of Immunology.

In The Last Decade

C. P. Worman

61 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. P. Worman United Kingdom 19 830 611 335 235 216 61 1.2k
TJ Hamblin United Kingdom 14 472 0.6× 426 0.7× 250 0.7× 307 1.3× 283 1.3× 25 1.0k
JC Cawley United Kingdom 19 487 0.6× 493 0.8× 241 0.7× 197 0.8× 234 1.1× 46 1.0k
RW Schroff United States 7 444 0.5× 359 0.6× 284 0.8× 265 1.1× 204 0.9× 9 965
DL Longo United States 18 603 0.7× 233 0.4× 323 1.0× 108 0.5× 256 1.2× 31 1.2k
RA Warnke United States 14 365 0.4× 257 0.4× 531 1.6× 162 0.7× 175 0.8× 31 992
DA Carson United States 13 426 0.5× 881 1.4× 558 1.7× 92 0.4× 338 1.6× 16 1.3k
MF Martelli Italy 15 506 0.6× 214 0.4× 544 1.6× 91 0.4× 229 1.1× 30 1.2k
WC Chan United States 19 707 0.9× 405 0.7× 959 2.9× 97 0.4× 219 1.0× 26 1.6k
H Mellstedt Sweden 17 432 0.5× 193 0.3× 161 0.5× 297 1.3× 271 1.3× 36 874
JM Pesando United States 9 454 0.5× 284 0.5× 305 0.9× 469 2.0× 228 1.1× 15 996

Countries citing papers authored by C. P. Worman

Since Specialization
Citations

This map shows the geographic impact of C. P. Worman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. P. Worman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. P. Worman more than expected).

Fields of papers citing papers by C. P. Worman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. P. Worman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. P. Worman. The network helps show where C. P. Worman may publish in the future.

Co-authorship network of co-authors of C. P. Worman

This figure shows the co-authorship network connecting the top 25 collaborators of C. P. Worman. A scholar is included among the top collaborators of C. P. Worman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. P. Worman. C. P. Worman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nicolaides, K. H., et al.. (2008). Changes in maternal plasma macrophage-colony stimulating factor levels during normal pregnancy. Clinical & Laboratory Haematology. 17(1). 57–59. 3 indexed citations
2.
Jewell, Andrew P., C. P. Worman, Frank Giles, & A H Goldstone. (1997). Serum Levels of TNF, IL-6 and sCD23 Correlate with Changes in Lymphocyte Count in Patients with B-Cell Chronic Lymphocytic Leukaemia Receiving Interferon-Alpha Therapy. Leukemia & lymphoma. 24(3-4). 327–333. 13 indexed citations
3.
Jewell, Andrew P., et al.. (1994). Serum macrophage colony‐stimulating factor (M‐CSF) levels correlate with clinical response to interferon‐alpha in patients with early‐stage B‐CLL. British Journal of Haematology. 86(2). 441–443. 7 indexed citations
4.
Ehrenstein, Michael R., et al.. (1993). Appearance of anti‐DNA antibodies in patients treated with interferon‐α. Arthritis & Rheumatism. 36(2). 279–280. 43 indexed citations
5.
Giles, Francis J., C. P. Worman, A. V. Hoffbrand, et al.. (1993). Recombinant interferon alfa 2 a in the treatment of patients with early stage B chronic lymphocytic leukaemia. British Journal of Haematology. 85(1). 77–83. 21 indexed citations
6.
Jewell, Andrew P., C. P. Worman, Frank Giles, A. H. Goldstone, & Peter M. Lydyard. (1992). Resistance of Chronic Lymphocytic Leukaemia Cells to Interferon-α Generated Lymphokine Activated Killer Cells. Leukemia & lymphoma. 7(5-6). 473–480. 15 indexed citations
7.
Lim, Seah H., C. P. Worman, Andrew P. Jewell, & A. H. Goldstone. (1991). Cellular cytotoxic function and potential in acute myelogenous leukaemia. Leukemia Research. 15(7). 641–644. 9 indexed citations
8.
Lim, Seah H., C. P. Worman, Andrew Jewell, & Anthony H. Goldstone. (1991). Production of tumour-derived suppressor factor in patients with acute myeloid leukaemia. Leukemia Research. 15(4). 263–268. 15 indexed citations
9.
Wiesholzer, Martin, et al.. (1991). Detection of BLT substrate-specific proteases in individual human peripheral blood leucocytes and bone marrow cells. Journal of Immunological Methods. 142(2). 147–155. 14 indexed citations
10.
Lim, Seah H., et al.. (1991). Lymphocyte activation and serine-esterase induction following recombinant interleukin-2 infusion for lymphomas and acute leukaemias. Cancer Immunology Immunotherapy. 33(2). 133–137. 8 indexed citations
11.
Lim, Seah H., et al.. (1991). Continuous intravenous infusion of high dose recombinant interleukin 2 for advanced lymphomas—A phase II study. Leukemia Research. 15(6). 435–440. 11 indexed citations
12.
Lim, Seah H., C. P. Worman, & Anthony H. Goldstone. (1991). Lymphocyte activation in patients with acute myeloid leukaemia Evidence for the presence of myeloblast antigen?. Cancer Immunology Immunotherapy. 33(6). 417–420. 4 indexed citations
13.
Bröker, Barbara M., Lorenzo Moretta, Ermanno Ciccone, et al.. (1990). Tγδ Cells and their Subsets in Blood and Synovial Tissue from Rheumatoid Arthritis Patients. Scandinavian Journal of Immunology. 32(6). 585–593. 60 indexed citations
14.
Worman, C. P., Fadime Yüksel, B. Yüksel, et al.. (1990). Tγδ Cell Subsets in Cord and Adult Blood. Scandinavian Journal of Immunology. 32(5). 491–495. 13 indexed citations
15.
Sunder‐Plassmann, Gere, et al.. (1990). Upregulation of a lymphoid serine protease in kidney allograft recipients. Kidney International. 37(5). 1350–1356. 13 indexed citations
16.
17.
Bröker, Barbara M., Pierre Youinou, Jean Jouquan, et al.. (1988). Chronic lymphocytic leukemic (CLL) cells secrete multispecific autoantibodies. Journal of Autoimmunity. 1(5). 469–481. 137 indexed citations
18.
Giles, Frank, Stephen J. Russell, C. P. Worman, et al.. (1988). Atypical Mycobacterial Infection in Alpha Interferon-Treated Hairy Cell Leukaemia. Acta Haematologica. 80(3). 159–161. 1 indexed citations
19.
Mills, Kingston H. G., Richard Armitage, & C. P. Worman. (1983). An indirect rosette technique for the identification and separation of human lymphocyte populations by monoclonal antibodies: A comparison with immunof. Immunology Letters. 6(5). 241–246. 17 indexed citations
20.
Linch, David C., John C. Cawley, C. P. Worman, et al.. (1981). Abnormalities of T‐Cell Subsets in Patients with Neutropenia and an Excess of Lymphocytes in the Bone Marrow. British Journal of Haematology. 48(1). 137–145. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by TJ Hamblin Breakdown of academic impact, for papers by JC Cawley Breakdown of academic impact, for papers by RW Schroff Breakdown of academic impact, for papers by DL Longo Breakdown of academic impact, for papers by RA Warnke Breakdown of academic impact, for papers by DA Carson Breakdown of academic impact, for papers by MF Martelli Breakdown of academic impact, for papers by WC Chan Breakdown of academic impact, for papers by H Mellstedt Breakdown of academic impact, for papers by JM Pesando
Rankless by CCL
2026